CLUSTER filed Apr 22, 2026 at 18:27 ET
Two Dyne Therapeutics directors, Jason Rhodes and Dirk Kersten, sold a combined $423K in open-market stock over a 2-day window (April 22-23, 2026). The sales represent approximately 0.014% of the company's $3.0B market cap, a trivial amount with no material economic signal. This follows a larger cluster of director sales totaling $4.97M over the prior week, but the current cluster is too small to indicate a change in outlook.